Compare DSGR & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DSGR | OCUL |
|---|---|---|
| Founded | 1952 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.5B |
| IPO Year | 1995 | 2014 |
| Metric | DSGR | OCUL |
|---|---|---|
| Price | $35.07 | $6.61 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 12 |
| Target Price | ★ $35.00 | $26.00 |
| AVG Volume (30 Days) | 178.7K | ★ 3.7M |
| Earning Date | 11-02-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 212.50 | N/A |
| EPS | ★ 0.19 | N/A |
| Revenue | ★ $1,980,023,000.00 | $1,990,000.00 |
| Revenue This Year | $7.71 | $1.71 |
| Revenue Next Year | $4.63 | $93.12 |
| P/E Ratio | $184.47 | ★ N/A |
| Revenue Growth | ★ 9.75 | 3.48 |
| 52 Week Low | $19.02 | $6.00 |
| 52 Week High | $35.30 | $16.44 |
| Indicator | DSGR | OCUL |
|---|---|---|
| Relative Strength Index (RSI) | 65.75 | 33.25 |
| Support Level | $34.87 | $6.23 |
| Resistance Level | $35.30 | $9.93 |
| Average True Range (ATR) | 0.10 | 0.44 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 35.21 | 34.00 |
Distribution Solutions Group Inc is a specialty distribution company providing value-added distribution solutions to the maintenance, repair and operations (MRO), original equipment manufacturer (OEM) and industrial technology markets. The company operates through four reportable segments: Lawson, TestEquity, Gexpro Services and Canada Branch Division. Lawson distributes specialty products and services to the industrial, commercial, institutional and government MRO marketplace. TestEquity, which generates maximum revenue, distributes test and measurement equipment and solutions, industrial and electronic production supplies and vendor managed inventory programs. Gexpro Services is a supply chain solutions provider. The company generates majority of its revenue from United States.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.